Difficulty: Medium
Average Score: 92%
Practice
In asthmatics, mast cell degranulation on the cell surface could be inhibited by the following EXCEPT:
Correct answer
D
Rationale
The correct answer is D) Pindolol. In asthmatics, mast cell degranulation is a key process that leads to the release of inflammatory mediators like histamine, leukotrienes, and prostaglandins, exacerbating asthma symptoms. Pindolol is a non-selective beta-blocker that acts on beta-adrenergic receptors, which are not involved in inhibiting mast cell degranulation.
A) Terbutaline is a beta-2 adrenergic agonist that can inhibit mast cell degranulation by activating beta-2 adrenergic receptors, leading to bronchodilation and reducing asthma symptoms.
B) Ketotifen is a mast cell stabilizer that inhibits the release of inflammatory mediators from mast cells, thereby preventing mast cell degranulation and reducing asthma symptoms.
C) Aminophylline is a methylxanthine derivative that can inhibit mast cell degranulation by increasing intracellular cAMP levels, which in turn suppresses the release of inflammatory mediators from mast cells.
Educational Context:
Understanding how different drugs affect mast cell degranulation in asthma is crucial for healthcare professionals managing patients with respiratory conditions. It helps in selecting the most appropriate medications to control asthma symptoms effectively. Knowing the mechanisms of action of various drugs can guide clinical decision-making and improve patient outcomes.
A) Terbutaline is a beta-2 adrenergic agonist that can inhibit mast cell degranulation by activating beta-2 adrenergic receptors, leading to bronchodilation and reducing asthma symptoms.
B) Ketotifen is a mast cell stabilizer that inhibits the release of inflammatory mediators from mast cells, thereby preventing mast cell degranulation and reducing asthma symptoms.
C) Aminophylline is a methylxanthine derivative that can inhibit mast cell degranulation by increasing intracellular cAMP levels, which in turn suppresses the release of inflammatory mediators from mast cells.
Educational Context:
Understanding how different drugs affect mast cell degranulation in asthma is crucial for healthcare professionals managing patients with respiratory conditions. It helps in selecting the most appropriate medications to control asthma symptoms effectively. Knowing the mechanisms of action of various drugs can guide clinical decision-making and improve patient outcomes.